half life of glp-1 agonists Structure and half-lives native human GLP-1, liraglutide and GLP-1 receptor agonists | How

Impaired neurogenesis in adult type-2 diabetic rats

Hanmi Pharmaceutical Role & Responsibilities: Hanmi is advancing multi-receptor agonists to address obesity and related metabolic conditions

reported greater weight loss in obese mice with the GLP-1/GIP/glucagon receptor triagonist compared to GLP-1 receptor agonists, GIP/GLP-1 receptor co-agonists and GLP-1/glucagon receptor agonists including semaglutide and tirzepatide [60]

Specifically, rodent studies showed an increased incidence of thyroid C-cell tumours (medullary thyroid carcinoma) when exposed to GLP-1 receptor agonists at doses significantly higher than those used therapeutically in humans

Discussion The three trials summarized in TABLE 2 provide consistent evidence that GLP-1 RAs may be an advantageous alternative to prandial insulin as add-on therapy to basal insulin

Another potential explanation for the differential effect could be discrepancy in the study population